BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30504336)

  • 1. Autoimmune hemolytic anemia.
    Hill A; Hill QA
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):382-389. PubMed ID: 30504336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in diagnosis and treatment of autoimmune hemolytic anemia].
    Kamesaki T
    Rinsho Ketsueki; 2019; 60(9):1100-1107. PubMed ID: 31597833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis.
    Moore DC; Arnall JR
    Ann Pharmacother; 2023 Aug; 57(8):970-977. PubMed ID: 36476151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody based therapeutics for autoimmune hemolytic anemia.
    Cavallaro F; Barcellini W; Fattizzo B
    Expert Opin Biol Ther; 2023; 23(12):1227-1237. PubMed ID: 37874225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold agglutinin disease.
    Berentsen S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):226-231. PubMed ID: 27913484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I treat cold agglutinin disease.
    Berentsen S
    Blood; 2021 Mar; 137(10):1295-1303. PubMed ID: 33512410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hemolytic anemia.
    Čermák J; Písačka M
    Vnitr Lek; 2018; 64(5):514-519. PubMed ID: 30193520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
    Premnath N; Pandey U; Pandey M; Venuprasad K
    Eur J Haematol; 2023 Sep; 111(3):506-508. PubMed ID: 37282755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies for treatment of cold agglutinin disease.
    Gelbenegger G; Berentsen S; Jilma B
    Expert Opin Biol Ther; 2023 May; 23(5):395-406. PubMed ID: 37128907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement inhibitors to treat IgM-mediated autoimmune hemolysis.
    Wouters D; Zeerleder S
    Haematologica; 2015 Nov; 100(11):1388-95. PubMed ID: 26521297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
    Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
    Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sutimlimab for treatment of cold agglutinin disease: why, how and for whom?
    Berentsen S; Barcellini W; D'Sa S; Jilma B
    Immunotherapy; 2022 Oct; 14(15):1191-1204. PubMed ID: 35946351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
    Berentsen S; Fattizzo B; Barcellini W
    Front Immunol; 2023; 14():1180509. PubMed ID: 37168855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I manage patients with cold agglutinin disease.
    Berentsen S
    Br J Haematol; 2018 May; 181(3):320-330. PubMed ID: 29363757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel anti-complement therapeutics for hemolytic anemia].
    Nishimura JI
    Rinsho Ketsueki; 2023; 64(6):466-473. PubMed ID: 37407469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical therapy for primary autoimmune hemolytic anemia in adults.
    Fatone MC; Cirasino L
    Clin Exp Med; 2023 Jul; 23(3):727-736. PubMed ID: 35980482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology in complement-mediated hemolytic disorders.
    Bortolotti M; Barcellini W; Fattizzo B
    Eur J Haematol; 2023 Sep; 111(3):326-336. PubMed ID: 37308291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
    Jäger U; D'Sa S; Schörgenhofer C; Bartko J; Derhaschnig U; Sillaber C; Jilma-Stohlawetz P; Fillitz M; Schenk T; Patou G; Panicker S; Parry GC; Gilbert JC; Jilma B
    Blood; 2019 Feb; 133(9):893-901. PubMed ID: 30559259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Hemolysis: Diagnosis and Treatment Recommendations.
    Barcellini W
    Semin Hematol; 2015 Oct; 52(4):304-12. PubMed ID: 26404442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.